As "soap operas" go this is a winner. The wheels and gears starting to whirr and spin frantically as SOOOOOOO MANY THINGS...coalesce!
This must have been a very difficult decision for Nader. CytoDyn/Leronlimab, "his "baby" devoured most of his waking hours for the last few years. Being the recipient of copious abuse, as his name and aspirations were dragged repetitiously through the mud and worse...Nader finally stepped down.
Thank you, Nader, for your caring and efforts on behalf of Leronlimab and humanity. But your efforts were not without serious merit...look at where CytoDyn stands today. Yes, the share price is a disaster (or a tremendous, in my opinion, BUY!!!), but this unique company/drug have traveled a long challenging journey over the last harried years. We now stand at the apex of a veritable mountain of achievement after extraordinary struggles to get to this point.
Yes, by rights, Nader's work should have secured the recognition Leronlimab deserved and in a perfect world, it would have happened saving hundreds of thousands of Covid-stricken lives. Unfortunately, smaller minds prevailed and dollars trumped lives! (May they BIH!)
So...Thank you Nader Pourhassan Ph. D.!
Now we move on...
the cancellation of the CC led to speculation, but I seriously doubt anyone foresaw this event.
Nader's obvious humanity are now a memory and new hands will drive this formidable biotech into the future. I suspect the next "driver" will be in contrast to what we have seen up to now...LOL.
Those who have been defiling everything CytoDyn/Leronlimab/Pourhassan are suddenly immersed in a quandary as they struggle to read, "the writing on the wall." Big wheels are "aturnin'" and as cogs mesh gears grind to the flash of brass and smell of lubricant. "Just how short am I?" flashes between neurons as the realization hits home...
Smile Nader. The crows are coming home to roost.
News 
Market Data 
Discover 
